Roundtable
How is the increasing complexity of modalities reshaping CDMO differentiation and specialization strategies?
Pharma's Almanac
PAO-05-26-RT-02May 27, 2026
ADC Platform
From mAbs to ADCs: Rethinking the Platform Manufacturing Model
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-11May 11, 2026
Rare Disease
Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment
Quotient Sciences
PR-04-26-02Apr 1, 2026
ADCs
Improved Efficacy and Safety Driving Resurging Interest in ADCs
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-09-25-NI-05Sep 22, 2025
Remarketing
Why Remarketing Belongs in Every CDMO’s Marketing Plan
Emilee Kudla
Pharma's Almanac
PAO-07-25-NI-12Jul 24, 2025
Industrial Vacuums
Delfin Enhances Pharmaceutical Manufacturing with Advanced Containment and Conveying Systems
Dimitri Di Salvo; Frank Intrieri Jr.
Delfin Industrial Corporation
PAO-04-24-PHEX-25Jun 17, 2025
Flexibility
Flexible CDMO Solutions — Reducing Risk and Accelerating Time to Market
Justin Lacombe, Ph.D.; Sheetal Muley, Ph.D.
Experic
PAO-04-25-CL-06May 23, 2025
HPAPI
BioDuro Opens Shanghai Laboratory for Highly Potent Compound Synthesis
BioDuro
PR-03-25-NI-07Mar 25, 2025
Antibody-Drug Conjugates
Reducing ADC Development Timelines with Integrated Development and Manufacturing Services
Thomas Rohrer
Samsung Biologics
PAO-11-23-CL-01Nov 13, 2023
HPAPIs
An Introduction to HPAPIs and Cytotoxic Drugs
Roots Analysis
PAO-04-23-CL-04Apr 25, 2023
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
Olon
PR-M09-22-06Sep 26, 2022
Complex Chemistry
Solving Complex Chemical Problems Across All Phases of NCE Programs
Luigi Trussardo
Olon
PAO-10-21-CL-11Oct 21, 2021
Process Development
Designing More Sustainable Small Molecule API Manufacturing Processes
Arne Grumann; Marko Salo
Fermion
PAO-09-21-CL-05Sep 16, 2021
Biocompatibility
Championing In Vitro Biocompatibility/Biological Reactivity Testing for Plastics Used in Pharma Manufacturing
Janmeet Anant; Monica Cardona
MilliporeSigma
PAO-06-21-CL-09Jun 21, 2021
High Potency
Streamlining Highly Potent Drug Commercialization
Robert Klehr; Uwe Korn; Norbert Straub
Fareva
PAO-04-21-CL-04Apr 19, 2021
HPAPI
A Successful Approach for Managing Unexpected Increases in Potency for HPAPIs
Daniela Kovats
Fareva
PAO-01-21-CL-01Jan 11, 2021
Small Molecule
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
Pierre Luzeau, Ph.D.
Seqens
PAP-Q4-20-CL-025Dec 9, 2020
Specialized OSD Services
Avara Pharmaceutical Services: Specialization with a Client-Centric Approach
Deborah A. Graham
Avara Pharmaceutical Services
PAP-Q4-20-CL-003Dec 9, 2020
SEQENS Inaugurates HPAPI Unit
Seqens
PR-M08-20-NI-47Aug 28, 2020
Expansion
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
Catalent
PR-M08-20-NI-13Aug 7, 2020